228 related articles for article (PubMed ID: 27102082)
1. Assessment of morbidity following regional nodal dissection in the axilla and groin for metastatic melanoma.
Theodore JE; Frankel AJ; Thomas JM; Barbour AP; Bayley GJ; Allan CP; Wagels M; Smithers BM
ANZ J Surg; 2017 Jan; 87(1-2):44-48. PubMed ID: 27102082
[TBL] [Abstract][Full Text] [Related]
2. Quality of life after axillary or groin sentinel lymph node biopsy, with or without completion lymph node dissection, in patients with cutaneous melanoma.
de Vries M; Hoekstra HJ; Hoekstra-Weebers JE
Ann Surg Oncol; 2009 Oct; 16(10):2840-7. PubMed ID: 19639366
[TBL] [Abstract][Full Text] [Related]
3. Deep lymph node metastases in the groin significantly affects prognosis, particularly in sentinel node-positive melanoma patients.
Niebling MG; Wevers KP; Suurmeijer AJ; van Ginkel RJ; Hoekstra HJ
Ann Surg Oncol; 2015 Jan; 22(1):279-86. PubMed ID: 25008028
[TBL] [Abstract][Full Text] [Related]
4. Morbidity and recurrence after completion lymph node dissection following sentinel lymph node biopsy in cutaneous malignant melanoma.
Guggenheim MM; Hug U; Jung FJ; Rousson V; Aust MC; Calcagni M; Künzi W; Giovanoli P
Ann Surg; 2008 Apr; 247(4):687-93. PubMed ID: 18362633
[TBL] [Abstract][Full Text] [Related]
5. The survival benefit to patients with positive sentinel node melanoma after completion lymph node dissection may be limited to the subgroup with a primary lesion Breslow thickness greater than 1.0 and less than or equal to 4 mm (pT2-pT3).
Nowecki ZI; Rutkowski P; Michej W
Ann Surg Oncol; 2008 Aug; 15(8):2223-34. PubMed ID: 18506535
[TBL] [Abstract][Full Text] [Related]
6. Complications following completion lymphadenectomy versus therapeutic lymphadenectomy for melanoma - A systematic review of the literature.
Moody JA; Botham SJ; Dahill KE; Wallace DL; Hardwicke JT
Eur J Surg Oncol; 2017 Sep; 43(9):1760-1767. PubMed ID: 28756017
[TBL] [Abstract][Full Text] [Related]
7. In transit/local recurrences in melanoma patients after sentinel node biopsy and therapeutic lymph node dissection.
Rutkowski P; Nowecki ZI; Zurawski Z; Dziewirski W; Nasierowska-Guttmejer A; Switaj T; Ruka W
Eur J Cancer; 2006 Jan; 42(2):159-64. PubMed ID: 16324835
[TBL] [Abstract][Full Text] [Related]
8. Complete lymph node dissection for regional nodal metastasis.
Dzwierzynski WW
Clin Plast Surg; 2010 Jan; 37(1):113-25. PubMed ID: 19914463
[TBL] [Abstract][Full Text] [Related]
9. Completion Lymph Node Dissection Based on Risk of Nonsentinel Metastasis in Cutaneous Melanoma of the Head and Neck.
Fritsch VA; Cunningham JE; Lentsch EJ
Otolaryngol Head Neck Surg; 2016 Jan; 154(1):94-103. PubMed ID: 26399717
[TBL] [Abstract][Full Text] [Related]
10. A longitudinal comparison of arm morbidity in stage I-II breast cancer patients treated with sentinel lymph node biopsy, sentinel lymph node biopsy followed by completion lymph node dissection, or axillary lymph node dissection.
Kootstra JJ; Hoekstra-Weebers JE; Rietman JS; de Vries J; Baas PC; Geertzen JH; Hoekstra HJ
Ann Surg Oncol; 2010 Sep; 17(9):2384-94. PubMed ID: 20221902
[TBL] [Abstract][Full Text] [Related]
11. Morbidity after inguinal sentinel lymph node biopsy and completion lymph node dissection in patients with cutaneous melanoma.
de Vries M; Vonkeman WG; van Ginkel RJ; Hoekstra HJ
Eur J Surg Oncol; 2006 Sep; 32(7):785-9. PubMed ID: 16806794
[TBL] [Abstract][Full Text] [Related]
12. [Optimal treatment of the axilla after positive sentinel lymph node biopsy in early invasive breast cancer. Early results of the OTOASOR trial].
Sávolt A; Musonda P; Mátrai Z; Polgár C; Rényi-Vámos F; Rubovszky G; Kovács E; Sinkovics I; Udvarhelyi N; Török K; Kásler M; Péley G
Orv Hetil; 2013 Dec; 154(49):1934-42. PubMed ID: 24292111
[TBL] [Abstract][Full Text] [Related]
13. Optimal extent of completion lymphadenectomy for patients with melanoma and a positive sentinel node in the groin.
Verver D; Madu MF; Oude Ophuis CMC; Faut M; de Wilt JHW; Bonenkamp JJ; Grünhagen DJ; van Akkooi ACJ; Verhoef C; van Leeuwen BL
Br J Surg; 2018 Jan; 105(1):96-105. PubMed ID: 29095479
[TBL] [Abstract][Full Text] [Related]
14. Impact of Completion Lymph Node Dissection on Patients with Positive Sentinel Lymph Node Biopsy in Melanoma.
Lee DY; Lau BJ; Huynh KT; Flaherty DC; Lee JH; Stern SL; O'Day SJ; Foshag LJ; Faries MB
J Am Coll Surg; 2016 Jul; 223(1):9-18. PubMed ID: 27236435
[TBL] [Abstract][Full Text] [Related]
15. International multi-institutional management and outcome of melanoma patients with positive sentinel lymph nodes in more than one nodal basin.
Melstrom LG; Taylor E; Kuk D; Frankel TL; Panageas K; Haydu L; Sabel MS; Thompson JF; Ariyan C; Coit DG; Brady MS
Ann Surg Oncol; 2014 Dec; 21(13):4324-9. PubMed ID: 24962937
[TBL] [Abstract][Full Text] [Related]
16. Ultrasound mapping of lymph node and subcutaneous metastases in patients with cutaneous melanoma: results of a prospective multicenter study.
Blum A; Schmid-Wendtner MH; Mauss-Kiefer V; Eberle JY; Kuchelmeister C; Dill-Müller D
Dermatology; 2006; 212(1):47-52. PubMed ID: 16319474
[TBL] [Abstract][Full Text] [Related]
17. Risk evaluation in cutaneous melanoma patients undergoing lymph node dissection: impact of POSSUM.
Egberts F; Hartje C; Schafmayer C; Kaehler KC; von Schönfels W; Hauschild A; Becker T; Egberts JH
Ann R Coll Surg Engl; 2011 Oct; 93(7):514-22. PubMed ID: 22004633
[TBL] [Abstract][Full Text] [Related]
18. Incidence and location of positive nonsentinel lymph nodes in head and neck melanoma.
Gyorki DE; Boyle JO; Ganly I; Morris L; Shaha AR; Singh B; Wong RJ; Shah JP; Busam K; Kraus D; Coit DG; Patel S
Eur J Surg Oncol; 2014 Mar; 40(3):305-10. PubMed ID: 24361245
[TBL] [Abstract][Full Text] [Related]
19. Is there a relation between type of primary melanoma treatment and the development of intralymphatic metastasis? A review of the literature.
Sloot S; Speijers MJ; Bastiaannet E; Hoekstra HJ
Cancer Treat Rev; 2016 Apr; 45():120-8. PubMed ID: 27015564
[TBL] [Abstract][Full Text] [Related]
20. Early (sentinel lymph node biopsy-guided) versus delayed lymphadenectomy in melanoma patients with lymph node metastases : personal experience and literature meta-analysis.
Pasquali S; Mocellin S; Campana LG; Bonandini E; Montesco MC; Tregnaghi A; Del Fiore P; Nitti D; Rossi CR
Cancer; 2010 Mar; 116(5):1201-9. PubMed ID: 20066719
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]